Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological Review
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological Review
Authors
Keywords
Biomarkers, Phase II clinical investigation, Phase III clinical investigation, Personalized medicine, Research errors, Clinical research design, Clinical trials, Decision making
Journal
PLoS One
Volume 11, Issue 2, Pages e0149803
Publisher
Public Library of Science (PLoS)
Online
2016-02-25
DOI
10.1371/journal.pone.0149803
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reinventing clinical trials: a review of innovative biomarker trial designs in cancer therapies
- (2015) Ja-An Lin et al. BRITISH MEDICAL BULLETIN
- Missing steps in a staircase: a qualitative study of the perspectives of key stakeholders on the use of adaptive designs in confirmatory trials
- (2015) Munyaradzi Dimairo et al. Trials
- Adaptive Clinical Trial Design
- (2014) Shein-Chung Chow Annual Review of Medicine
- Methodology of clinical trials for rare diseases
- (2014) Catrin Tudur Smith et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Adaptive designs for clinical trials assessing biomarker-guided treatment strategies
- (2014) J Wason et al. BRITISH JOURNAL OF CANCER
- A comparison of Bayesian adaptive randomization and multi-stage designs for multi-arm clinical trials
- (2014) James M. S. Wason et al. STATISTICS IN MEDICINE
- Biomarker driven population enrichment for adaptive oncology trials with time to event endpoints
- (2014) Cyrus Mehta et al. STATISTICS IN MEDICINE
- Precision Medicine Clinical Trials: Defining New Treatment Strategies
- (2014) Brandy M. Heckman-Stoddard et al. Seminars in Oncology Nursing
- Adaptive enrichment designs for clinical trials
- (2013) N. Simon et al. BIOSTATISTICS
- Trial Designs for Personalizing Cancer Care: A Systematic Review and Classification
- (2013) P. Tajik et al. CLINICAL CANCER RESEARCH
- Marker Sequential Test (MaST) design
- (2013) Boris Freidlin et al. Clinical Trials
- Genomic Biomarkers for Personalized Medicine: Development and Validation in Clinical Studies
- (2013) Shigeyuki Matsui Computational and Mathematical Methods in Medicine
- A review of phase II trial designs for initial marker validation
- (2013) Sumithra J. Mandrekar et al. Contemporary Clinical Trials
- Group sequential designs for developing and testing biomarker-guided personalized therapies in comparative effectiveness research
- (2013) Tze Leung Lai et al. Contemporary Clinical Trials
- Design of oncology clinical trials: A review
- (2013) Revathi Ananthakrishnan et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Evaluating Many Treatments and Biomarkers in Oncology: A New Design
- (2013) Richard Kaplan et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Clinical Trials That Integrate Treatment and Biomarker Evaluation
- (2013) Boris Freidlin et al. JOURNAL OF CLINICAL ONCOLOGY
- Statistical and Practical Considerations for Clinical Evaluation of Predictive Biomarkers
- (2013) M.-Y. C. Polley et al. JNCI-Journal of the National Cancer Institute
- Biomarker enrichment strategies: matching trial design to biomarker credentials
- (2013) Boris Freidlin et al. Nature Reviews Clinical Oncology
- Biomarker-based adaptive trials for patients with glioblastoma--lessons from I-SPY 2
- (2013) B. M. Alexander et al. NEURO-ONCOLOGY
- Clinical trials for precision oncology using next-generation sequencing
- (2013) Richard Simon et al. Personalized Medicine
- A generalized Dunnett test for multi-arm multi-stage clinical studies with treatment selection
- (2012) D. Magirr et al. BIOMETRIKA
- Efficacy and tolerability of rizatriptan in pediatric migraineurs: Results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design
- (2012) Tony W Ho et al. CEPHALALGIA
- A 2-Stage Phase II Design with Direct Assignment Option in Stage II for Initial Marker Validation
- (2012) M.-W. An et al. CLINICAL CANCER RESEARCH
- Reports from the 2010 Clinical and Translational Cancer Research Think Tank Meeting: Design Strategies for Personalized Therapy Trials
- (2012) D. A. Berry et al. CLINICAL CANCER RESEARCH
- Novel Strategies to Test Biological Hypotheses in Early Drug Development for Advanced Prostate Cancer
- (2012) R. Ferraldeschi et al. CLINICAL CHEMISTRY
- Clinical trial designs for testing biomarker-based personalized therapies
- (2012) Tze Leung Lai et al. Clinical Trials
- Randomized Phase II Trial Designs With Biomarkers
- (2012) Boris Freidlin et al. JOURNAL OF CLINICAL ONCOLOGY
- Incorporating biomarkers into clinical trial designs: points to consider
- (2012) Edward Bradley NATURE BIOTECHNOLOGY
- From drug discovery to biomarker-driven clinical trials in lymphoma
- (2012) Anas Younes et al. Nature Reviews Clinical Oncology
- Cancer biomarkers: selecting the right drug for the right patient
- (2012) Gary J. Kelloff et al. NATURE REVIEWS DRUG DISCOVERY
- Study Designs and Statistical Analyses for Biomarker Research
- (2012) Masahiko Gosho et al. SENSORS
- Bayesian clinical trials in action
- (2012) J. Jack Lee et al. STATISTICS IN MEDICINE
- A two-stage Bayesian design for co-development of new drugs and companion diagnostics
- (2012) Stella Wanjugu Karuri et al. STATISTICS IN MEDICINE
- Current development in clinical trials: issues old and new
- (2012) David L. DeMets STATISTICS IN MEDICINE
- Clinical trials for predictive medicine
- (2012) Richard Simon STATISTICS IN MEDICINE
- Optimal design of multi-arm multi-stage trials
- (2012) James M. S. Wason et al. STATISTICS IN MEDICINE
- Adaptive trial designs: a review of barriers and opportunities
- (2012) John A Kairalla et al. Trials
- The BATTLE to Personalize Lung Cancer Prevention through Reverse Migration
- (2011) Kathryn A. Gold et al. Cancer Prevention Research
- Adaptive Clinical Trial Designs for Simultaneous Testing of Matched Diagnostics and Therapeutics
- (2011) H. I. Scher et al. CLINICAL CANCER RESEARCH
- Vasopressors and the search for the optimal trial design
- (2011) Ritesh Maharaj Contemporary Clinical Trials
- Integrating biomarkers in clinical trials
- (2011) Marc Buyse et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Implementing prognostic and predictive biomarkers in CRC clinical trials
- (2011) Sandra Van Schaeybroeck et al. Nature Reviews Clinical Oncology
- Adaptive clinical trials in oncology
- (2011) Donald A. Berry Nature Reviews Clinical Oncology
- Integrating predictive biomarkers and classifiers into oncology clinical development programmes
- (2011) Robert A. Beckman et al. NATURE REVIEWS DRUG DISCOVERY
- Predictive biomarkers in colorectal cancer: usage, validation, and design in clinical trials
- (2011) Qian Shi et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Statistical Considerations for the Next Generation of Clinical Trials
- (2011) Wenting Wu et al. SEMINARS IN ONCOLOGY
- The Cross-Validated Adaptive Signature Design
- (2010) B. Freidlin et al. CLINICAL CANCER RESEARCH
- A threshold sample-enrichment approach in a clinical trial with heterogeneous subpopulations
- (2010) Aiyi Liu et al. Clinical Trials
- A Bayesian adaptive design with biomarkers for targeted therapies
- (2010) Jens C Eickhoff et al. Clinical Trials
- Clinical trials for predictive medicine: new challenges and paradigms
- (2010) Richard Simon Clinical Trials
- Predictive biomarker validation in practice: lessons from real trials
- (2010) Sumithra J Mandrekar et al. Clinical Trials
- The efficiency of clinical trial designs for predictive biomarker validation
- (2010) KY Young et al. Clinical Trials
- Bayesian adaptive randomization designs for targeted agent development
- (2010) J. Jack Lee et al. Clinical Trials
- Biostatistic Tools in Pharmacogenomics - Advances, Challenges, Potential
- (2010) Yasunori Sato et al. CURRENT PHARMACEUTICAL DESIGN
- An introduction to adaptive designs and adaptation in CNS trials
- (2010) Vladimir Dragalin EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Adaptive design clinical trials and trial logistics models in CNS drug development
- (2010) Sue-Jane Wang et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Phase II clinical trials in oncology: are we hitting the target?
- (2010) Mei-Kim Ang et al. Expert Review of Anticancer Therapy
- Adaptive design clinical trials: Methodology, challenges and prospect
- (2010) Rajiv Mahajan et al. INDIAN JOURNAL OF PHARMACOLOGY
- Adaptive Methods: Telling “The Rest of the Story”
- (2010) Scott S. Emerson et al. Journal of Biopharmaceutical Statistics
- Outcome-Adaptive Randomization: Is It Useful?
- (2010) Edward L. Korn et al. JOURNAL OF CLINICAL ONCOLOGY
- Design, Operation, and Interpretation of Clinical Trials
- (2010) B.L. Pihlstrom et al. JOURNAL OF DENTAL RESEARCH
- Biomarkers and surrogate end points—the challenge of statistical validation
- (2010) Marc Buyse et al. Nature Reviews Clinical Oncology
- An adaptive seamless phase II/III design for oncology trials with subpopulation selection using correlated survival endpoints†
- (2010) Martin Jenkins et al. PHARMACEUTICAL STATISTICS
- Biomarker-adaptive clinical trial designs
- (2010) Boris Freidlin et al. PHARMACOGENOMICS
- Exploring the benefits of adaptive sequential designs in time-to-event endpoint settings
- (2010) Sarah C. Emerson et al. STATISTICS IN MEDICINE
- Incorporation of Biomarker Assessment in Novel Clinical Trial Designs: Personalizing Brain Tumor Treatments
- (2010) Evanthia Galanis et al. Current Oncology Reports
- Adaptive patient enrichment designs in therapeutic trials
- (2009) Sue-Jane Wang et al. BIOMETRICAL JOURNAL
- Effective Incorporation of Biomarkers into Phase II Trials
- (2009) L. M. McShane et al. CLINICAL CANCER RESEARCH
- I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy
- (2009) AD Barker et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Trial Designs for Predictive Biomarker Validation: One Size Does Not Fit All
- (2009) Sumithra J. Mandrekar et al. Journal of Biopharmaceutical Statistics
- Clinical Trial Designs for Predictive Biomarker Validation: Theoretical Considerations and Practical Challenges
- (2009) Sumithra J. Mandrekar et al. JOURNAL OF CLINICAL ONCOLOGY
- Utility of Adaptive Strategy and Adaptive Design for Biomarker-facilitated Patient Selection in Pharmacogenomic or Pharmacogenetic Clinical Development Program
- (2009) Sue-Jane Wang JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- On Two-stage Seamless Adaptive Design in Clinical Trials
- (2009) Shein-Chung Chow et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Methodological aspects of lung cancer clinical trials in the era of targeted agents
- (2009) Massimo Di Maio et al. LUNG CANCER
- Genomic markers for decision making: what is preventing us from using markers?
- (2009) Vicky M. Coyle et al. Nature Reviews Clinical Oncology
- Clinical trial designs for evaluating the medical utility of prognostic and predictive biomarkers in oncology
- (2009) Richard Simon Personalized Medicine
- Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncology
- (2009) Werner Brannath et al. STATISTICS IN MEDICINE
- How do multi-stage, multi-arm trials compare to the traditional two-arm parallel group design – a reanalysis of 4 trials
- (2009) FM-S Barthel et al. Trials
- Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial
- (2009) Matthew R Sydes et al. Trials
- Group Sequential and Adaptive Designs - A Review of Basic Concepts and Points of Discussion
- (2008) Marc Vandemeulebroecke BIOMETRICAL JOURNAL
- Statistical Issues in Translational Cancer Research
- (2008) S. L. George CLINICAL CANCER RESEARCH
- The Use of Genomics in Clinical Trial Design
- (2008) R. Simon CLINICAL CANCER RESEARCH
- Randomized Phase III Clinical Trial Designs for Targeted Agents
- (2008) A. Hoering et al. CLINICAL CANCER RESEARCH
- Bayesian adaptive design for targeted therapy development in lung cancer — a step toward personalized medicine
- (2008) Xian Zhou et al. Clinical Trials
- Speeding up the Evaluation of New Agents in Cancer
- (2008) M. K. B. Parmar et al. JNCI-Journal of the National Cancer Institute
- Adaptive design methods in clinical trials – a review
- (2008) Shein-Chung Chow et al. Orphanet Journal of Rare Diseases
- Adaptive Clinical Trials
- (2008) Christopher S Coffey et al. Drugs in research & development
- Development and validation of biomarker classifiers for treatment selection
- (2007) Richard Simon JOURNAL OF STATISTICAL PLANNING AND INFERENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started